Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139.
Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA 02139.
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16240-16249. doi: 10.1073/pnas.1904513116. Epub 2019 Jul 29.
Rapid and reliable detection of ultralow-abundance nucleic acids and proteins in complex biological media may greatly advance clinical diagnostics and biotechnology development. Currently, nucleic acid tests rely on enzymatic processes for target amplification (e.g., PCR), which have many inherent issues restricting their implementation in diagnostics. On the other hand, there exist no protein amplification techniques, greatly limiting the development of protein-based diagnosis. We report a universal biomolecule enrichment technique termed hierarchical nanofluidic molecular enrichment system (HOLMES) for amplification-free molecular diagnostics using massively paralleled and hierarchically cascaded nanofluidic concentrators. HOLMES achieves billion-fold enrichment of both nucleic acids and proteins within 30 min, which not only overcomes many inherent issues of nucleic acid amplification but also provides unprecedented enrichment performance for protein analysis. HOLMES features the ability to selectively enrich target biomolecules and simultaneously deplete nontargets directly in complex crude samples, thereby enormously enhancing the signal-to-noise ratio of detection. We demonstrate the direct detection of attomolar nucleic acids in urine and serum within 35 min and HIV p24 protein in serum within 60 min. The performance of HOLMES is comparable to that of nucleic acid amplification tests and near million-fold improvement over standard enzyme-linked immunosorbent assay (ELISA) for protein detection, being much simpler and faster in both applications. We additionally measured human cardiac troponin I protein in 9 human plasma samples, and showed excellent agreement with ELISA and detection below the limit of ELISA. HOLMES is in an unparalleled position to unleash the potential of protein-based diagnosis.
在复杂的生物介质中快速可靠地检测超低丰度核酸和蛋白质,可以极大地推动临床诊断和生物技术的发展。目前,核酸检测依赖于酶促过程进行靶标扩增(例如 PCR),但这些过程存在许多固有问题,限制了其在诊断中的应用。另一方面,目前还没有蛋白质扩增技术,这极大地限制了基于蛋白质的诊断的发展。我们报告了一种通用的生物分子富集技术,称为分级纳流控分子富集系统(HOLMES),用于无扩增的分子诊断,该技术使用大规模并行和分级级联的纳流控浓缩器。HOLMES 在 30 分钟内实现了核酸和蛋白质的亿倍富集,不仅克服了核酸扩增的许多固有问题,而且为蛋白质分析提供了前所未有的富集性能。HOLMES 具有直接在复杂的粗样品中选择性富集靶标生物分子并同时耗尽非靶标物质的能力,从而极大地提高了检测的信噪比。我们在 35 分钟内直接检测到尿液和血清中的皮摩尔核酸,在 60 分钟内检测到血清中的 HIV p24 蛋白。HOLMES 的性能可与核酸扩增测试相媲美,在蛋白质检测方面比标准酶联免疫吸附测定(ELISA)提高了近百万倍,在这两种应用中都更加简单和快速。我们还测量了 9 个人血浆样本中的人心肌肌钙蛋白 I 蛋白,与 ELISA 结果具有极好的一致性,检测结果低于 ELISA 的检测限。HOLMES 在释放基于蛋白质的诊断的潜力方面具有无与伦比的地位。